A Phase 1 Study of PRT3645 in Participants With Select Advanced or Metastatic Solid Tumors
Conditions: Breast Cancer; Glioblastoma; Head and Neck Squamous Cell Carcinoma; Malignant Mesothelioma; Non-small Cell Lung Cancers; Sarcoma Intervention: Drug: PRT3645 Sponsor: Prelude Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Asbestosis | Cancer | Cancer & Oncology | Carcinoma | Mesothelioma | Research | Sarcomas | Study